Answers to CME examination

Answers to CME examination

Kang, Kauls, and Gaspari 983 J AM ACAD DERMATOL VOLUME 54, NUMBER 6 222. Gaspari AA, Sauder DN. Immunotherapy of basal cell carcinoma: evolving appr...

45KB Sizes 1 Downloads 42 Views

Kang, Kauls, and Gaspari 983

J AM ACAD DERMATOL VOLUME 54, NUMBER 6

222. Gaspari AA, Sauder DN. Immunotherapy of basal cell carcinoma: evolving approaches. Dermatol Surg 2003;29:1027-34. 223. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Let 2003;85: 85-95. 224. Heil F, Ahmad-Nejad P, Hemmi H, Hochrein H, Ampenberger F, Gellert T, et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 2003;33: 2987-97.

225. Goodman MG. A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine. Pharm Biotechnol 1995;6:581-609. 226. Agarwala SS, Kirkwood JM, Bryant J. Phase I, randomized, double-blind trial of 7-allyl-8-oxoguanosine (loxoribine) in advanced cancer. Cytokines Cell Mol Ther 2000;6:171-6. 227. Lotzova E, Savary CA, Khan A, Stringfellow DA. Stimulation of natural killer cells in two random-bred strains of athymic rats by interferon-inducing pyrimidone. J Immunol 1984;132: 2566-70.

Answers to CME examination Identification No. 806-206 June 2006 issue of the Journal of the Academy of Dermatology

Questions 1-31, Kang SSW, Kauls LS, Gaspari AA. J Am Acad Dermatol 2006;54:951-83.

1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16.

c e e a e e d e a e a c b b b d

17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31.

e a b b a e e e e d c a b b e